Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Equillium (EQ) Research & Development (2022 - 2025)

Equillium (EQ) has disclosed Research & Development for 4 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 79.0% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Dec 2025, down 49.62% year-over-year, with the annual reading at $12.8 million for FY2025, 65.69% down from the prior year.
  • Research & Development for Q4 2025 was $1.5 million at Equillium, up from $400000.0 in the prior quarter.
  • The five-year high for Research & Development was $10.8 million in Q2 2024, with the low at $400000.0 in Q3 2025.
  • Average Research & Development over 4 years is $7.7 million, with a median of $9.1 million recorded in 2023.
  • The sharpest move saw Research & Development rose 12.47% in 2024, then crashed 95.82% in 2025.
  • Over 4 years, Research & Development stood at $8.5 million in 2022, then increased by 7.73% to $9.2 million in 2023, then fell by 20.35% to $7.3 million in 2024, then tumbled by 79.0% to $1.5 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $1.5 million, $400000.0, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.